Busy Philipps Empowers Women with ADHD to Go from Feeling Misrepresented to Being ‘Ms. Represented’ in First-of-its-Kind Campaign with Supernus Pharmaceuticals

Company Overview - Supernus Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases [15] - The company has a diverse neuroscience portfolio that includes approved treatments for ADHD, dyskinesia in Parkinson's disease, epilepsy, migraine, and other CNS disorders [16] Product Information - Qelbree (viloxazine extended-release capsules) is a prescription medicine used to treat ADHD in adults and children aged 6 years and older [6] - Qelbree is a novel, once-a-day, non-stimulant approach for ADHD treatment and is the first non-stimulant approved for adults with ADHD in 20 years [4] - As a non-stimulant, Qelbree has no evidence of abuse or misuse and can be conveniently refilled without needing a new prescription each month [4] Campaign and Awareness - The 'Ms. Represented' campaign, in partnership with Busy Philipps, aims to empower women with ADHD to understand their symptoms and seek help [1][4] - The campaign highlights the often-misrepresented experiences of women with ADHD, focusing on the differences in symptom presentation between genders [2][3] - Increased awareness of ADHD symptoms among females is leading to more women seeking diagnosis and treatment [3] Market Insights - Studies indicate that boys are twice as likely as girls to be diagnosed with ADHD, resulting in many women remaining undiagnosed or misdiagnosed until adulthood [3] - The campaign seeks to address the disparity in ADHD diagnosis and treatment between males and females [4]